Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Unkind cytokines: current evidence for the potential role of cytokines in immune-mediated depression.
Correction: MRI Correlates of Disability in African-Americans with Multiple Sclerosis.
The Retinal Nerve Fiber Layer of Patients With Neuromyelitis Optica and Chronic Relapsing Optic Neuritis is More Severely Damaged than Patients With Multiple Sclerosis.
Spinal anesthesia for cesarean delivery in a woman with neuromyelitis optica.
Cerebrospinal fluid analysis in infectious diseases of the nervous system: when to ask, what to ask, what to expect.
Magnetic resonance spectroscopic findings of chronic lesions in two subtypes of multiple sclerosis: primary progressive versus relapsing remitting.
Deep grey matter involvement in multiple sclerosis: key player or bystander?
The molecular study of IFNβ pleiotropic roles in MS treatment.
Impaired functional integration in multiple sclerosis: a graph theory study.
Interdisciplinary exchange of ideas: progestagens for autoimmunity, biologics for pregnancy complications.
Evaluation of the Innermost Retinal Layers and Visual Evoked Potentials in Patients with Multiple Sclerosis.
[Magnetic resonance imaging of the brain in the monitoring of immune therapy of multiple sclerosis].
Occurrence of CCSVI in patients with MS and its relationship with iron metabolism and varicose veins.
Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders.
Adverse events after endovascular treatment of chronic cerebro-spinal venous insufficiency (CCSVI) in patients with multiple sclerosis.
Risk factors related to cardiovascular diseases and the metabolic syndrome in multiple sclerosis - a systematic review.
Serum 25(OH) Vitamin D levels is not associated with disability in multiple sclerosis patients: A case-control study.
[Alemtuzumab is a new drug based on monoclonal antibodies for treatment multiple sclerosis: treatment possibilities and risks(review)].
Assessment of a program to encourage the multidisciplinary management of urinary disorders in multiple sclerosis.
Re: Hutchinson M, Fox RJ, Havrdova E, et al. Efficacy and safety of BG-12 (dimethyl fumarate) and other disease modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison. Curr Med
The new era of multiple sclerosis therapy.
Cloning, sequencing, expression and function of a cDNA encoding a receptor for the opioid growth factor, [Met(5)]enkephalin.
Longitudinally extensive transverse myelitis with AQP4 antibodies revealing ovarian teratoma.
Early detection of thrombin activity in neuroinflammatory disease.
[Oral treatments in multiple sclerosis].

Pages